Boehringer Ingelheim Sets $91 Million Shanghai Expansion

Boehringer Ingelheim announced a $91 million expansion of its Shanghai manufacturing facility, which is located in Zhangjiang High-Tech Park. The German company positioned the investment as a “for China” strategy. The latest boost to BI’s China facilities follows a $149 million investment two years ago at the same site, aimed at increasing the company’s offerings in vaccines and animal health. More details.... Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});